Anabolic Steroids Control Act Exposed

The Anabolic Steroids Control Act does not include adoption or approval information, but it was included in the 1995 ALEC Sourcebook of American State Legislation. ALEC has attempted to distance itself from this piece of legislation after the launch of ALECexposed.org in 2011, but it has done nothing to get it repealed in the states where it previously pushed for it to be made into law.

ALEC Bill Text

Summary

The Food and Drug Administration's Anabolic Steroid Investigation inventory, which started in 1985 and includes over 300,00 enteries, does not have any citations for products which are combinations of estrogen with anabolic steroids. These are important medications needed for the treatment of women with hormone deficiencies. Current state law still places restrictions on health professionals who legitiamtely handle these products. This is an unnecessary burden on pharmacists and physicians, and can impede the treatment process for women. This bill legally changes the definition of "anabolic steroid" to exclude a combination of estrogen with anabolic steroid which is expressly intended for administration to hormone deficient women.

Model Legislation

{Title, enacting clause, etc.}

Section 1

This Act may be cited as the Anabolic Steroids Control Act.

Section 2. {Anabolic Steroid Penalties.}

A. Additon of Anabolic Steroids to Schedule III. Schedule III of Section (insert appropriate section) of the (insert state) Controlled Substances Act (or insert appropriate act) is amended by adding at the end the following: "Anabolic Steroids."

B. Definitions of Anabolic Steroid. Section (insert appropriate section) of the Controlled Substances Act (or insert appropriate act) is amended by adding at the end the following:

1. the term "anabolic steroid" means any drug or hormone substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, and corticosteroids) that promotes muscle growth, and includes:

• boldenone,

• chlorotestosterone,

• clostebol,

• dehydrochlormethyltestosterone,

• dihydrostestosterone,

• drostanolone,

• ethylestrenol,

• fluoxymesterone,

• formebulone,

• mesterolone,

• methandienone,

• methandranone,

• methandriol,

• methandrostenolone,

• methanolone,

• methyltestosterone,

• mibolerone,

• nandrolone,

• nandrolone,

• norethandrolone,

• oxandrolone,

• oxymesterone,

• oxymetholone,

• stanolone

• stanomolol,

• Testolactone,

• Testosterone,

• Trenbolone, and

• Any salt, ester, or isomer of a drug or substance described or listed in this paragraph, if that salth, ester, or isomer promotes muscle growth.

C. Except as provided in section 2(c) such term does not include an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species. Also, except as provided in section 2(c) such term does not include an anabolic steroid which is a combination of estrogen with anabolic steroid and which is expressly intended for administration to hormone deficient women.

D. If any person prescribes, dispenses, or distrubutes an anabolic steroid intended for administration through implants to nonhuman species, for human use, such person shall be considered to have prescribed, dispensed, or distributed an anabolic steroid within the meaning of Section 2(B). If an person prescribes, dispenses, or distributes an anabolic steroid which is a combination of estrogens with methyltestosterone and which is intended for administration to hormone deficient women, for use by persons who are not hormone deficient women, such person shall be considered to have prescribed, dispensed, or distributed an anabolic steroid within the meaning of Section 2(B).

E. Effective Date. This Section and the amendment made by this Section shall take effect 90 days after the date of enactment of this Act.

Section 3. {Administrative Regulations Abuse Potential.}

The Secretary of the Department of Health may by regulation exempt any compund, mixture or preparation containing a substance in paragraph (B) of Section 2 of the (insert state) Controlled Substances Act (insert appropriate act)(as added by Section 2 of this Act) from the application of all or any part of the Controlled Substances Act, if, because of its concentration, preparation, mixture, or delivery system, it has no significant potential for abuse.

Section 4. {Severability clause.}

Section 5. {Repealer clause.}

Section 6. {Effective date.}